Bolt Biotherapeutics Inc

NAS:BOLTHealthcarenasdaq_composite

$4.31+6.68%At closeAt close · Wed 21 Oct · ≈ AED 15.83 · Market cap $8.3M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−17,370.6%	−5,904.4%	−1,176.4%	−681.4%	100.0%	80.6%	—	—
Operating margin	−21,290.9%	−7,364.1%	−1,576.6%	−967.4%	−949.9%	−450.1%	−450.1%	+0.0 pts
Net margin	−26,289.2%	−7,824.7%	−1,537.8%	−878.6%	−820.8%	−433.7%	−433.7%	+0.0 pts
EBITDA margin	−21,026.4%	−7,730.0%	−1,508.7%	−855.0%	−864.2%	−414.4%	—	—
Return on equity	57.9%	−39.4%	−51.4%	−61.4%	−110.4%	−125.9%	−125.9%	+0.0 pts
Return on assets	−130.5%	−32.0%	−38.7%	−43.3%	−63.4%	−58.8%	−58.8%	+0.0 pts
Return on capital employed	−139.4%	−32.4%	−44.1%	−54.7%	−87.2%	−71.7%	—	—
Debt / equity	−0.1×	0.1×	0.1×	0.2×	0.4×	0.9×	0.9×	+0.0%
Debt / assets	23.4%	7.9%	9.9%	12.7%	25.3%	40.5%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	2.3×	8.9×	7.5×	5.2×	3.2×	3.6×	3.6×	+0.0%
Quick ratio	2.3×	8.9×	7.5×	5.2×	3.2×	3.6×	—	—
Cash ratio	0.5×	1.3×	0.4×	0.5×	0.5×	1.4×	1.4×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.1×	0.1×	—	—
Receivables turnover	—	6.3×	—	—	6.6×	7.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.